missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Integrin alpha 4 beta 7 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 5397-A3-050
This item is not returnable.
View return policy
Description
The Recombinant Human Integrin alpha 4 beta 7 Protein is derived from CHO. The Recombinant Human Integrin alpha 4 beta 7 Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and MgCl 2 . | |
| M.W. Observed: 130-155 kDa and 100-130 kDa, under reducing conditions. | |
| 50μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 3676 | |
| Integrin alpha 4 beta 7/LPAM-1 | |
| Chinese Hamster Ovary cell line,CHO-derived human Integrin alpha 4 beta 7/LPAM-1 protein, (N-terminus) Human Integrin alpha 4 (Tyr34-Gln970 (R591L & R878Q)) Accession &Num; P13612 Acidic tail HHHHHH Human Integrin beta 7 (Glu20-His723) Accession &Num; P26010 Basic tail (C-terminus) | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction